Granite Point Capital Management, L.P. Forte Biosciences, Inc. Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding FBRX
# of Institutions
34Shares Held
19MCall Options Held
1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$2.14 Million0.57% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$1.93 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$1.76 Million0.06% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$1.2 Million1.95% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$1.08 Million0.01% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $12M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.